ただ今実施中のプロモーション | 詳細はこちら >>
30690
INK128
Activators & Inhibitors

INK128 #30690

Reviews ()
Citations (0)

Western blot analysis of extracts from 293T cells, untreated (-) or treated with INK128 (100 nM, 1 hr; +), using Phospho-p70 S6 Kinase (Thr389) (D5U1O) Rabbit mAb #97596 (upper), or p70 S6 Kinase (49D7) Rabbit mAb #2708 (lower).

Chemical structure of INK128.

Product Usage Information

INK128 is supplied as a lyophilized powder. For a 15 mM stock, reconstitute 5 mg of powder in 1.07 ml of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

Storage:

Store lyophilized at -20ºC, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Product Description

Molecular Weight: 309.3 g/mol

Purity: >98%

Molecular Formula: C15H15N7O

CAS: 1224844-38-5

Solubility: Soluble in DMSO at 25 mg/ml.

Background

INK128, also known as MLN0128, is a second-generation active-site mTOR inhibitor (asTORi). Treating cells with INK128 leads to the dephosphorylation of mTOR downstream targets including p70 S6 kinase and 4E-BP1 (1,2). Research has proven that INK128 is an effective mTOR inhibitor because it targets both the mTORC1 and mTORC2 complexes at a high potency (Ki = 1.4nM) (1). Studies have shown that INK128 has anti-leukemic effects and can induce apoptosis at higher concentrations (3).

  1. Hsieh, A.C. et al. (2012) Nature 485, 55-61.
  2. Vilar, E. et al. (2011) Mol Cancer Ther 10, 395-403.
  3. Zeng, Z. et al. (2016) Oncotarget 7, 55083-55097.
For Research Use Only. Not For Use In Diagnostic Procedures.

Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

To Purchase # 30690S
製品番号 サイズ 価格 在庫
30690S
5 mg

Powered By OneLink